Generic Pharmasec successfully executes order from Reliance Group

27 Jul 2021 Evaluate

In line with the company's strategy to extend Point of Care Diagnostic footprint by focusing on Channel and Dealers network and thereby enhancing its sales turnover, Generic Pharmasec has successfully executed an order from Reliance Group for upgrading Point of Care Diagnostics by installing Abbot Point of Care I-Stat Blood Analysers at their group hospitals namely, Sir H. N. Reliance Hospital at Mumbai, Reliance Foundation Hospital at Jamnagar, Reliance Industries Hospitals at Bharuch and at Surat.

The Company is in dialogue with Reliance Group for further orders and implementation for their Group hospitals at various other locations.

Generic Pharmasec will now increase its focus on creating high value propositions for all hospitals in India for all their Critical Diagnostic Requirements. To Increase the footprint in the country & improve access to Critical Diagnostic Solutions in Tier-2 & Tier-3 towns, Generic Pharmasec will appoint 15 new sub-distributors over the course of the next 24 months in such identified towns across the country.

Genpharmasec Share Price

3.39 -0.08 (-2.31%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sudarshan Chemicals 1130.35
Bodal Chemicals 69.83
Shree Pushkar Chem 351.95
Kiri Industries 658.80
Bhageria Industries 201.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.